期刊文献+

类固醇性糖尿病诊治进展 被引量:8

下载PDF
导出
摘要 类固醇性糖尿病(SDM)是最常见的药物相关性糖尿病,属于糖代谢障碍的一种特殊类型,多是由于外源性应用糖皮质激素或内源性肾上腺皮质类固醇分泌异常增多而引起,归属于继发性糖尿病范畴.糖皮质激素(GC)属于类固醇激素,属21碳甾体激素,生理剂量的GC在机体内广泛存在且具有重要作用,既能参与并调控脂肪、糖、蛋白质的代谢,而且在钾、钠和水代谢过程起重要作用,同时能起到平衡机体内外环境的作用,药理剂量的GC主要有抑制免疫、抗炎、抗休克和抗毒等作用[1],目前GC的临床应用遍布各系统疾病。
机构地区 滨州医学院
出处 《青岛医药卫生》 2014年第6期452-454,共3页 Qingdao Medical Journal
  • 相关文献

参考文献14

  • 1糖皮质激素类药物临床应用指导原则(节选)[J].药物不良反应杂志,2011,13(1):40-44. 被引量:39
  • 2Lundgren M,Buren J,Ruge T,et al.Glucocorticoids down regulate glucose uptake capacity and insulin-signaling proteins in o-mental but not subcutaneous human adipocytes.J Clin Endocrinol Metab,2004,89(6):2989-2997.
  • 3冯凯,陆召麟,臧美孚,陈杰,王姮.162例库欣综合征糖代谢异常的临床资料分析[J].中国医学科学院学报,2000,22(3):266-268. 被引量:14
  • 4Penfomis A,Kury-Paulin S.Immunosuppressive drug-induced diabetes.Diabetes Metal,2006,32:539-546.
  • 5邹伏英,王友莲.类固醇糖尿病的诊断与治疗进展[J].中华风湿病学杂志,2013,17(8):564-566. 被引量:20
  • 6梁文龙,王颖.类固醇糖尿病18例临床分析[J].山东医药,1997,37(7):13-13. 被引量:4
  • 7Gurwitz J,Bohn R,Glynn R,et al.Glucocorticoids and the risk for initiation of hypoglycemia therapy.Arch Intern Med,1994,154 (1):97-101.
  • 8Kern W,Fehm HL.Glucocorticoid-induced diabetes mellitus in gastrointestinal diseases.Z Gastroenterol,1999,1 (Supp):36-42.
  • 9Raul Ariza-Andraca C B-F L.Risk factors fors teroid diabetes in rheumatic patients.Arch Med Res,1998,29(3):259-262.
  • 10Uboldi F,Carlo-Stella N,Belloli L,et al.Glucose blood levels after intra-articular steroid injection in diabetic and non-diabetic patients.Clin Rheumatol,2009,28:491-492.

二级参考文献20

  • 1陆召麟,协和内分泌和代谢学,1999年,1123页
  • 2Compston J. Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol, 2010, 6: 82-88.
  • 3Trikudanathan S, McMabon GT. Optimum management of gluco- corticoid-treated patients. Nat Clin Pract Endocrinol Metab, 2008, 4: 262-271.
  • 4Gulliford MC, Charlton J, Latinovic R. Risk of diabetes associ- ated with prescribed glucocorticoids in a large population. Dia- betes Care, 2006, 29: 2728-2729.
  • 5Gurwitz JH, Bohn RL, Glynn RJ, et al. Glucocorticoids and the risk for initiation of hypoglycemie therapy. Arch Intern Med, 1994, 154: 97-101.
  • 6Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endoer Pract, 2009, 15: 469-474.
  • 7van Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest, 2009, 39: 81-93.
  • 8Penfomis A, Kury-Panlin S. Immunosuppressive drug-induced diabetes. Diabetes Metab, 2006, 32: 539-546.
  • 9Willi SM, Kennedy A, Wallace P, et al. Tmglitazone antago- nizes metabolic effects of glueocorticostemids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids and leptin. Diabetes, 2002, 51: 2895-2902.
  • 10Cosio FG, Kudva Y, van der Valde M, et al. New onset hyper- g/ycemia and diabetes are associated with increased cardiovascu- lar risk after kidney transplantation. Kidney Int, 2005, 67: 2415-2421.

共引文献73

同被引文献32

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部